| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $61.4M | -28.6% |
| SG&A Expense | $41.6M | -15.7% |
| Operating Income | -$108.4M | +21.7% |
| Net Income | -$102.1M | +25.0% |
| EPS (Basic) | -$1.86 | +25.6% |
| EPS (Diluted) | -$1.86 | +25.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.7M | -37.3% |
| Current Assets | $118.0M | -40.1% |
| Total Assets | $150.5M | -38.2% |
| Current Liabilities | $16.3M | -11.0% |
| Total Liabilities | $39.3M | -6.9% |
| Stockholders' Equity | $111.3M | -44.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.3M | +33.8% |
| Investing Cash Flow | $65.2M | +158.9% |
| Financing Cash Flow | $135K | +110.0% |